Belangrijkste concurrenten
Dividendrendement (Y) Dividendrendement (Y+1) k/w-verhouding (Y) Koers-boekwaarde (Y) EV/omzet (Y) Beurskap. / EBITDA (Y) Beurskap. / EBIT (Y) Kap.($)
- - - - - - - 23,84 mln.
-.--%-.--%50.09x8.14x12.19x43.93x45.2x 54,89 mld.
-.--%-.--%-33.09x66.12x83.99x-37.13x-36.57x 43,51 mld.
1,77%1,68%15.99x3.77x5.59x12.68x13.86x 38,12 mld.
-.--%-.--%-25.55x1.1x3.4x-9.97x-7.59x 23,14 mld.
-.--%-.--%17.37x3.28x4.28x11.35x12.11x 19,5 mld.
-.--%-.--%27.5x2.54x5.38x14.92x18.58x 17,25 mld.
-.--%-.--%-513.11x14.06x29.69x700.16x-597.17x 14,68 mld.
-.--%-.--%-14.2x - 178.64x-27.85x-13.87x 14,12 mld.
-.--%-.--%-197x23.8x48.58x-193.78x-167.83x 13,78 mld.
-.--%-.--%-58.84x21.72x13.23x-56.08x-50.56x 13,11 mld.
-.--%-.--%17.41x4.57x4.86x12.08x13.57x 11,94 mld.
-.--%-.--%-19.14x9.09x - -19.74x-19.07x 8,51 mld.
-.--%-.--%-18.6x15.44x18.52x-28.7x-18.01x 8,34 mld.
-.--%-.--%-10.39x-15.86x90.86x-12.75x-12.48x 8,03 mld.
-.--%-.--%-16.41x12.82x125.36x-19.07x-18.57x 7,29 mld.
Gemiddelde 0,12% 0,11% -51,87x 12,19x 44,61x 26,00x -55,89x 18,52 mld.
Gewogen gemiddelde per kap. 0,23% 0,22% -31,71x 16,47x 36,32x 25,34x -35,54x
Biotherapeutische geneesmiddelen